KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Interest Coverage Ratio data on record, last reported at 10.38 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 112.46% year-over-year to 10.38; the TTM value through Dec 2025 reached 6.39, down 130.94%, while the annual FY2025 figure was 6.39, 130.94% down from the prior year.
  • Interest Coverage Ratio reached 10.38 in Q4 2025 per AQST's latest filing, down from 4.13 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.02 in Q2 2024 and bottomed at 10.38 in Q4 2025.
  • Average Interest Coverage Ratio over 5 years is 4.36, with a median of 3.65 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: soared 100.65% in 2024, then plummeted 20754.23% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 6.69 in 2021, then increased by 2.96% to 6.49 in 2022, then soared by 73.5% to 1.72 in 2023, then tumbled by 183.98% to 4.89 in 2024, then plummeted by 112.46% to 10.38 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 10.38 in Q4 2025, 4.13 in Q3 2025, and 4.09 in Q2 2025.